Myriad Genetics
MYGN
MYGN
190 hedge funds and large institutions have $1.91B invested in Myriad Genetics in 2023 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 61 increasing their positions, 75 reducing their positions, and 28 closing their positions.
Holders
190
Holders Change
-7
Holders Change %
-3.55%
% of All Funds
3.04%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
23
Increased
61
Reduced
75
Closed
28
Calls
$17.1M
Puts
$70K
Net Calls
+$17.1M
Net Calls Change
+$15.8M
Top Buyers
Top Sellers
1 |
1
State Street
Boston,
Massachusetts
|
$107M |
2 |
2
Invesco
Atlanta,
Georgia
|
$9.83M |
3 |
3
Morgan Stanley
New York
|
$14.5M |
4 |
4
EARNEST Partners
Atlanta,
Georgia
|
$71.1M |
5 |
5
BlackRock
New York
|
$328M |